Cargando…
The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID‐19
Caly et al.(1) reported that ivermectin inhibited severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) in vitro for up to 48 hours using ivermectin at 5 μM. The concentration resulting in 50% inhibition (IC(50); 2 µM) was > 35× higher than the maximum plasma concentration (C(max)) after o...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267287/ https://www.ncbi.nlm.nih.gov/pubmed/32378737 http://dx.doi.org/10.1002/cpt.1889 |